Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrico Baraldi

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 13, 2024
The multifaceted nature of lack of access to antibiotics: types of shortage and specific causes, consequences, and solutionsEnrico Baraldi, Christine Årdal, Emil Aho, et al.
Journal of Pharmaceutical Policy and Practice|November 2, 2016
An assessment of the future impact of alternative technologies on antibiotics marketsEjike Nwokoro, Ross Leach, Christine Årdal, et al.
Journal of Medical Internet Research|August 14, 2020
Views of Implementers and Nonimplementers of Internet-Administered Cognitive Behavioral Therapy for Depression and Anxiety: Survey of Primary Care Decision Makers in SwedenAnders Brantnell, Joanne Woodford, Enrico Baraldi, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|August 28, 2018
Simulating Market Entry Rewards for Antibiotics DevelopmentChristopher Okhravi, Simone Callegari, Steve McKeever, et al.
Journal of Pharmaceutical Policy and Practice|April 11, 2018
Insights into early stage of antibiotic development in small- and medium-sized enterprises: a survey of targets, costs, and durationsChristine Årdal, Enrico Baraldi, Ursula Theuretzbacher, et al.
Npj Antimicrobials and Resistance|January 22, 2025
Policy options for sustainable access to off-patent antibiotics in EuropeDimitra Panteli, Michael Anderson, Thomas Fieldman, et al.
The Lancet. Infectious Diseases|July 11, 2017
To the G20: incentivising antibacterial research and developmentChristine Årdal, Enrico Baraldi, Francesco Ciabuschi, et al.
Bulletin of the World Health Organization|May 6, 2021
Supply chain transparency and the availability of essential medicinesChristine Årdal, Enrico Baraldi, Peter Beyer, et al.
Lancet (London, England)|February 12, 2023
Transferable exclusivity voucher: a flawed incentive to stimulate antibiotic innovationChristine Årdal, Enrico Baraldi, Reinhard Busse, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 13, 2024
The multifaceted nature of lack of access to antibiotics: types of shortage and specific causes, consequences, and solutionsEnrico Baraldi, Christine Årdal, Emil Aho, et al.
Journal of Pharmaceutical Policy and Practice|November 2, 2016
An assessment of the future impact of alternative technologies on antibiotics marketsEjike Nwokoro, Ross Leach, Christine Årdal, et al.
Journal of Medical Internet Research|August 14, 2020
Views of Implementers and Nonimplementers of Internet-Administered Cognitive Behavioral Therapy for Depression and Anxiety: Survey of Primary Care Decision Makers in SwedenAnders Brantnell, Joanne Woodford, Enrico Baraldi, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|August 28, 2018
Simulating Market Entry Rewards for Antibiotics DevelopmentChristopher Okhravi, Simone Callegari, Steve McKeever, et al.
Journal of Pharmaceutical Policy and Practice|April 11, 2018
Insights into early stage of antibiotic development in small- and medium-sized enterprises: a survey of targets, costs, and durationsChristine Årdal, Enrico Baraldi, Ursula Theuretzbacher, et al.
Npj Antimicrobials and Resistance|January 22, 2025
Policy options for sustainable access to off-patent antibiotics in EuropeDimitra Panteli, Michael Anderson, Thomas Fieldman, et al.
The Lancet. Infectious Diseases|July 11, 2017
To the G20: incentivising antibacterial research and developmentChristine Årdal, Enrico Baraldi, Francesco Ciabuschi, et al.
Bulletin of the World Health Organization|May 6, 2021
Supply chain transparency and the availability of essential medicinesChristine Årdal, Enrico Baraldi, Peter Beyer, et al.
Lancet (London, England)|February 12, 2023
Transferable exclusivity voucher: a flawed incentive to stimulate antibiotic innovationChristine Årdal, Enrico Baraldi, Reinhard Busse, et al.
Pageof 2